Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,042 | -77,905 | -58,920 | -40,686 | -19,680 |
| Depreciation Amortization | 544 | 919 | 428 | 113 | -49 |
| Accounts payable and accrued liabilities | -1,202 | 1,536 | 255 | 264 | 2,816 |
| Other Working Capital | -4,494 | -2,426 | -2,327 | -3,793 | -3,845 |
| Other Operating Activity | 3,656 | 14,211 | 12,136 | 7,957 | 1,223 |
| Operating Cash Flow | $-20,538 | $-63,665 | $-48,428 | $-36,145 | $-19,535 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,141 | 67,769 | 46,026 | 39,216 | 19,272 |
| PPE Investments | -14 | -1,669 | -1,450 | -551 | -58 |
| Investing Cash Flow | $13,127 | $66,100 | $44,576 | $38,665 | $19,214 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1 | 1 | 1 | 1 |
| Other Financing Activity | -33 | -750 | -558 | -441 | -344 |
| Financing Cash Flow | $-33 | $-749 | $-557 | $-440 | $-343 |
| Beginning Cash Position | 41,702 | 40,016 | 40,016 | 40,016 | 40,016 |
| End Cash Position | 34,258 | 41,702 | 35,607 | 42,096 | 39,352 |
| Net Cash Flow | $-7,444 | $1,686 | $-4,409 | $2,080 | $-664 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,538 | -63,665 | -48,428 | -36,145 | -19,535 |
| Capital Expenditure | -14 | -1,669 | -1,450 | -551 | -58 |
| Free Cash Flow | -20,552 | -65,334 | -49,878 | -36,696 | -19,593 |